Published in Clin Rheumatol on March 01, 1990
Cardiac tamponade and pericardial disorders in connective tissue diseases: case report and literature review. J Natl Med Assoc (1994) 0.88
Rheumatic disease among Oklahoma tribal populations: a cross-sectional study. J Rheumatol (2012) 0.85
Evidence of autoantibodies to cell membrane associated DNA (cultured lymphocytes): a new specific marker for rapid identification of systemic lupus erythematosus. Ann Rheum Dis (1998) 0.83
Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus. Clin Rheumatol (2005) 0.83
Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities. J Clin Immunol (2014) 0.81
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med (1967) 10.22
Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol (1982) 9.73
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet (1983) 6.71
Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med (1969) 6.16
Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum (1976) 5.33
Autoantibody to a nuclear antigen in proliferating cells. J Immunol (1978) 4.36
The anticardiolipin syndrome. J Rheumatol (1986) 3.36
The reaction of the lupus erythematosus (L.E.) cell factor with deoxyribonucleoprotein of the cell nucleus. J Clin Invest (1959) 2.56
Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol (1985) 2.51
Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med (1987) 2.47
Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum (1979) 2.23
THE APPLICATION OF THE FLUORESCENT ANTIBODY TECHNIC TO THE INVESTIGATION OF LUPUS ERYTHEMATOSUS AND VARIOUS DERMATOSES. J Invest Dermatol (1963) 1.95
Cross-reactivity of anti-DNA antibodies with proteoglycans. Clin Exp Immunol (1984) 1.80
A monoclonal anti-DNA antibody also binds to cell-surface protein(s). Proc Natl Acad Sci U S A (1984) 1.75
Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clin Exp Immunol (1985) 1.62
Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest (1982) 1.58
Significance of persisting serologic abnormalities in SLE. Arthritis Rheum (1976) 1.56
Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann Rheum Dis (1987) 1.53
Cellular protein and RNA antigens in autoimmune disease. Mol Biol Med (1984) 1.52
Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens. Eur J Immunol (1985) 1.44
The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Ann Intern Med (1987) 1.42
Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis (1986) 1.25
Detection of anti-dsDNA as diagnostic tool. Ann Rheum Dis (1981) 1.21
Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum (1987) 1.19
Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen. Arthritis Rheum (1979) 1.16
Patterns of antihistone antibody specificity in systemic rheumatic disease. I Systemic lupus erythematosus, mixed connective tissue disease, primary sicca syndrome, and rheumatoid arthritis with vasculitis. Arthritis Rheum (1985) 1.15
Antibodies to La, Jo-1, nRNP and Sm detected by multi-track immunoblotting using a novel filter holder: a comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjögren's syndrome. J Immunol Methods (1986) 1.14
The in vivo and in vitro glomerular deposition of isolated anti-double-stranded-DNA antibodies in NZB/W mice. Clin Immunol Immunopathol (1984) 1.08
Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity? Arthritis Rheum (1987) 1.08
Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol (1988) 1.08
Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol (1987) 1.07
Avidity of antibodies to dsDNA: comparison of IFT on Crithidia luciliae, Farr assay, and PEG assay. J Immunol (1982) 1.06
Antibodies to native DNA in discoid lupus erythematosus. Br J Dermatol (1974) 1.06
Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum (1987) 1.03
Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis (1988) 1.01
Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course. Rheumatol Int (1986) 0.97
Complement fixation by anti-dsDNA antibodies in SLE: measurement by radioimmunoassay and relationship with disease activity. Ann Rheum Dis (1986) 0.92
Anti La(SSB) identifies a distinctive subgroup of systemic lupus erythematosus. Br J Rheumatol (1988) 0.90
Central nervous system lupus erythematosus. The need for classification. Arthritis Rheum (1979) 0.89
Anti-protein kinase NII antibodies in rheumatic autoimmune diseases. J Biol Chem (1984) 0.87
Quantitation of antibodies to nucleoribonucleoprotein by ELISA: relation between antibody levels and disease activity in patients with connective tissue disease. Clin Exp Immunol (1985) 0.84
Abnormalities in the content of nucleic acids of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum (1982) 0.83
Anti-DNA antibodies of IgA class in patients with systemic lupus erythematosus. Rheumatol Int (1986) 0.81
The SL autoantibody-antigen system: clinical and biochemical studies. Ann Rheum Dis (1986) 0.81
Antinuclear antibodies in patients with systemic lupus erythematosus: a comparison of counterimmunoelectrophoresis and immunoblotting. Rheumatol Int (1987) 0.79
Clinical significance of anti-Sm antibodies in systemic lupus erythematosus. Am J Med (1983) 0.79
Antinuclear antibodies in the immunotaxonomy of connective tissue diseases. Scand J Rheumatol Suppl (1985) 0.79
Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis. Immunol Today (1985) 0.79
Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis. J Clin Lab Immunol (1984) 0.77
Antinuclear antibodies in lupus erythematosus and Sjögren's syndrome: clinical and immunological investigations. Scand J Rheumatol Suppl (1987) 0.75
Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum (2000) 6.46
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med (1995) 2.98
Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. Immunol Today (1990) 1.84
Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest (1994) 1.54
Characterization of the autoantigen calreticulin. J Immunol (1991) 1.42
[Immunology in medical practice. XXI. Laboratory tests for immunologic diseases]. Ned Tijdschr Geneeskd (1999) 1.39
[AIDS on Curaçao: the first 6 years]. Ned Tijdschr Geneeskd (1993) 1.38
[Determination of antibodies against double-stranded DNA; when and which test?]. Ned Tijdschr Geneeskd (1991) 1.38
Diuretic therapy in Afrocaribbeans with uncomplicated essential hypertension. Neth J Med (2000) 1.38
Cross-reactive binding patterns of monoclonal antibodies to DNA are often caused by DNA/anti-DNA immune complexes. Res Immunol (1989) 1.26
Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int (1992) 1.24
Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun (1990) 1.14
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology (Oxford) (2001) 1.10
Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity? Arthritis Rheum (1987) 1.08
The detection of anti-Ro/SS-A and anti-La/SS-B antibodies. A comparison of counterimmunoelectrophoresis with immunoblot, ELISA, and RNA-precipitation assays. J Immunol Methods (1990) 1.08
Dissociation of DNA/anti-DNA complexes at high pH. Immunol Commun (1980) 1.07
Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis (1989) 1.07
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology (Oxford) (1999) 1.06
Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Ann Rheum Dis (2004) 1.05
Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms? Arthritis Rheum (2003) 1.04
In vivo ANA is a fixation artifact: nucleosome-complexed antinucleosome autoantibodies bind to the cell surface and are internalized. J Am Soc Nephrol (1996) 1.00
Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis (1989) 1.00
Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations. Clin Exp Immunol (1990) 0.98
Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course. Clin Rheumatol (1995) 0.96
Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosus. Rheumatol Int (1989) 0.96
Antigen specificity of anti-nuclear antibodies complexed to nucleosomes determines glomerular basement membrane binding in vivo. Eur J Immunol (1997) 0.95
Antinuclear antibodies: cause of disease or caused by disease? Rheumatology (Oxford) (2000) 0.94
Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus. Lupus (2011) 0.93
Panniculitis as the first manifestation of systemic lupus erythematosus: description of two cases. Neth J Med (1993) 0.91
Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol Dial Transplant (1997) 0.91
Cerebral arteriovenous malformations in The Netherlands Antilles. High prevalence of hereditary hemorrhagic telangiectasia-related single and multiple cerebral arteriovenous malformations. Clin Neurol Neurosurg (1993) 0.91
Regulation of IL-12 production by human monocytes and the influence of prostaglandin E2. Ann N Y Acad Sci (1996) 0.90
Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension. Exp Hematol (1981) 0.90
An improved incubation apparatus for Western blots used for the detection of antinuclear antibodies. J Immunol Methods (1986) 0.90
Significance of anti-nuclear and anti-extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice. Clin Exp Immunol (1996) 0.89
Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies. J Immunol Methods (1994) 0.89
Increased rectal wall stiffness after prostate radiotherapy: relation with fecal urgency. Neurogastroenterol Motil (2012) 0.88
Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus? J Autoimmun (1998) 0.88
Fibrosing alveolitis predating microscopic polyangiitis. Scand J Rheumatol (1999) 0.87
Pneumatosis intestinalis in mixed connective tissue disease. Neth J Med (1992) 0.87
Low avidity antibodies to double stranded DNA in systemic lupus erythematosus: a longitudinal study of their clinical significance. Ann Rheum Dis (1989) 0.87
Patients with systemic lupus erythematosus with high plasma levels of sFas risk relapse. J Rheumatol (1999) 0.87
Characterization of murine monoclonal antibodies against 60-kD Ro/SS-A and La/SS-B autoantigens. Clin Exp Immunol (1995) 0.87
Cognitive and emotional disturbances in systemic lupus erythematosus. Psychother Psychosom (1991) 0.86
Autoimmunity and filariasis. Autoantibodies against cytoplasmic cellular proteins in sera of patients with onchocerciasis. J Immunol (1993) 0.86
Diagnostic criteria and immunopathogenesis of Sjögren's syndrome: implications for therapy. Immunol Today (1995) 0.86
Heparin and heparinoids prevent the binding of immune complexes containing nucleosomal antigens to the GBM and delay nephritis in MRL/lpr mice. Kidney Int (1996) 0.85
Antinuclear antibodies in routine analysis: the relevance of putative clinical associations. Ann Rheum Dis (1993) 0.85
Specificity of monoclonal anti-nucleosome auto-antibodies derived from lupus mice. J Autoimmun (1996) 0.84
Quantification of glomerular epithelial cell adhesion by using anti-DNA antibodies in ELISA. Hybridoma (1992) 0.84
A prospective study on antiribosomal P proteins in two cases of familial lupus and recurrent psychosis. Ann Rheum Dis (1990) 0.84
Systemic lupus erythematosus. Int J Clin Lab Res (1992) 0.84
Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation. Lupus (2001) 0.84
Sjögren's syndrome and retroviral infection. Arthritis Rheum (1992) 0.83
Maternal autoantibodies and congenital heart block: no evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile. Lupus (1993) 0.82
Following the disease course in systemic lupus erythematosus: are serologic variables of any use? J Rheumatol (1996) 0.82
Prevalence of antiphospholipid antibodies in patients with fetal loss. Ann Rheum Dis (1991) 0.82
Routine testing for antinuclear antibodies: a comparison of immunofluorescence, counterimmunoelectrophoresis and immunoblotting. J Autoimmun (1988) 0.81
Interference of IgG, IgG aggregates and immune complexes in tests for platelet autoantibodies. Br J Haematol (1983) 0.81
Low avidity antibodies to dsDNA as a diagnostic tool. Ann Rheum Dis (1989) 0.81
Psychiatric symptoms before systemic lupus erythematosus is diagnosed. Rheumatol Int (1994) 0.81
Technical problems concerning the use of immunoblots for the detection of antinuclear antibodies. J Immunol Methods (1990) 0.80
Analysis of heavy and light chain use of lupus-associated anti-La/SS-B and anti-Sm autoantibodies reveals two distinct underlying immunoregulatory mechanisms. Res Immunol (1992) 0.80
Daily stressors and systemic lupus erythematosus: a longitudinal analysis--first findings. Psychother Psychosom (1991) 0.80
Antinuclear antibodies in patients with systemic lupus erythematosus: a comparison of counterimmunoelectrophoresis and immunoblotting. Rheumatol Int (1987) 0.79
Binding of anti-DNA antibodies to glomerular heparan sulfate: a new clue for the pathogenesis of SLE nephritis? Nephrologie (1989) 0.79
Mapping of SLE-specific Sm B cell epitopes using murine monoclonal antibodies. J Autoimmun (1997) 0.79
The development of a quantitative assay for the detection of anti-Ro/SS-A and anti-LA/SS-B autoantibodies using purified recombinant proteins. J Immunol Methods (1992) 0.78
Production of anti-Ro/SS-A and anti-La/SS-B autoantibodies is closely coordinated in systemic lupus erythematosus and independent of anti-dsDNA production. J Autoimmun (1997) 0.78
Increased ferritin response in adult Still's disease: specificity and relationship to outcome. Scand J Rheumatol (2007) 0.78
Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis. Am J Pathol (1995) 0.78
Inhibition of association vs. dissociation of high-avidity DNA/anti-DNA complexes:possible involvement of secondary hydrogen bonds. Immunol Invest (1985) 0.78
Clinical connections: assays and assignment. Lupus (1997) 0.78
Fine specificities of anti-nuclear antibodies in murine models of graft-versus-host disease. Clin Exp Immunol (1990) 0.78
The distribution of HLA-B27 subtype in patients with ankylosing spondylitis in Northern Norway. Scand J Rheumatol (2014) 0.77
Monoclonal autoantibodies recognizing histone variants. Immunol Invest (1988) 0.77
Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway. Scand J Rheumatol (2009) 0.77
Pathophysiology of lupus nephritis: the role of nucleosomes. Neth J Med (1994) 0.77
Comparison between dissociation and inhibition of association of DNA/anti-DNA complexes. Immunol Commun (1983) 0.77
A new ELISA for the detection of anti-heparan sulfate reactivity, using photobiotinylated antigen. J Immunol Methods (1994) 0.77
Longstanding isolated cerebral systemic lupus erythematosus in an 8-year-old black girl. Resemblance with multiple sclerosis. Clin Neurol Neurosurg (1993) 0.76
Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus: comment on the article by Esdaile et al. Arthritis Rheum (1996) 0.76
Relation between serological data at the time of biopsy and renal histology in lupus nephritis. Rheumatol Int (1991) 0.76
Erythroleukaemia complicating ANA-negative systemic lupus erythematosus. Scand J Rheumatol (2007) 0.76
Prognostic factors in systemic lupus erythematosus. Rheumatol Int (1991) 0.76
Histone-containing immune complexes are to a large extent responsible for anti-dsDNA reactivity in the Farr assay of active SLE patients. J Autoimmun (2000) 0.75
Detection of retroviral antibodies in primary biliary cirrhosis. Lancet (1998) 0.75